Sale!

Bedaquiline Api

530.00

Applications

Bedaquiline is a crucial medicine in the global fight against tuberculosis, yet its high price places it out of reach for many patients.

Description

(αS,βR)-Bedaquiline is a diarylquinoline derivative that acts as a mycobacterial inhibitor.

Preparation

The preparation method comprises the following steps: enabling a compound (9) to be reacted with a reducing agent in a solvent; and then collecting racemate of bedaquiline from a reaction product.

Chemical Properties

Bedaquiline API is a white to off-white crystalline powder with low solubility in water, known for its antibiotic properties and specifically used to treat multidrug-resistant tuberculosis.

Definition

Bedaquiline API (Active Pharmaceutical Ingredient) is a medication employed for the treatment of multidrug-resistant tuberculosis, inhibiting mycobacterial ATP synthase.

Description

Product Name Bedaquiline Api
Country of Origin Made in India
Molar Mass 555.504 g/mol
Formula C32H31BrN2O2
Protein Binding 99.9%
Usage Pharma
Form Powder
Color White
Packaging Size As Per Requirement

Our Export Location as a Bedaquiline Api Manufacturer, Supplier, Exporter, Stockist from India.

Afghanistan

Albania

Algeria

Andorra

Angola

Antigua and Barbuda

Argentina

Armenia

Australia

Austria

Austrian Empire

Azerbaijan

Baden

Bahamas

Bahrain

Bangladesh

Barbados

Bavaria

Belarus

Belgium

Belize

Benin (Dahomey)

Bolivia

Liberia

Libya

Liechtenstein

Lithuania

Luxembourg

Madagascar

Malawi

Malaysia

Maldives

Mali

Malta

Marshall Islands

Mauritania

Mauritius

Mecklenburg-Schwerin

Mecklenburg-Strelitz

Mexico

Micronesia

Moldova

Monaco

Mongolia

Montenegro

Bosnia and Herzegovina

Botswana

Brazil

Brunei

Brunswick and Lüneburg

Bulgaria

Burkina Faso

Burma

Burundi

Cabo Verde

Cambodia

Cameroon

Canada

Cayman Islands

Central African Republic

Central American Federation

Chad

Chile

China

Colombia

Comoros

Congo Free State

Costa Rica

Morocco

Mozambique

Namibia

Nassau

Nauru

Nepal

Netherlands

New Zealand

Nicaragua

Niger

Nigeria

North German Confederation

North German Union

North Macedonia

Norway

Oldenburg

Oman

Orange Free State

Pakistan

Palau

Panama

Papal States

Cote d’Ivoire

Croatia

Cuba

Cyprus

Czechia

Czechoslovakia

Democratic Republic of the Congo

Denmark

Djibouti

Dominica

Dominican Republic

Duchy of Parma

East Germany

Ecuador

Egypt

El Salvador

Equatorial Guinea

Eritrea

Estonia

Eswatini

Ethiopia

Federal Government of Germany

Fiji

Papua New Guinea

Paraguay

Peru

Philippines

Piedmont-Sardinia

Poland

Portugal

Qatar

Republic of Genoa*

Republic of Korea (South Korea)

Republic of the Congo

Romania

Russia

Rwanda

Saint Kitts and Nevis

Saint Lucia

Saint Vincent and the Grenadines

Samoa

San Marino

Sao Tome and Principe

Saudi Arabia

Schaumburg-Lippe*

Finland

France

Gabon

Gambia

Georgia

Germany

Ghana

Grand Duchy of Tuscany

Greece

Grenada

Guatemala

Guinea

Guinea-Bissau

Guyana

Haiti

Hanover

Hanseatic Republics

Hawaii

Hesse

Holy See

Honduras

Hungary

Iceland

Senegal

Serbia

Seychelles

Sierra Leone

Singapore

Slovakia

Slovenia

Solomon Islands

Somalia

South Africa

South Sudan

Spain

Sri Lanka

Sudan

Suriname

Sweden

Switzerland

Syria

Tajikistan

Tanzania

Texas

Thailand

India

Indonesia

Iran

Iraq

Ireland

Israel

Italy

Jamaica

Japan

Jordan

Kazakhstan

Kenya

Kingdom of Serbia/Yugoslavia

Kiribati

Korea

Kosovo

Kuwait

Kyrgyzstan

Laos

Latvia

Lebanon

Lesotho

Lew Chew (Loochoo)

Timor-Leste

Togo

Tonga

Trinidad and Tobago

Tunisia

Turkey

Turkmenistan

Tuvalu

Two Sicilies*

Uganda

Ukraine

Union of Soviet Socialist Republics*

United Arab Emirates

United Kingdom

Uruguay

Uzbekistan

Vanuatu

Venezuela

Vietnam

Württemberg*

Yemen

Zambia

Zimbabwe

Reviews

There are no reviews yet.

Be the first to review “Bedaquiline Api”

Your email address will not be published. Required fields are marked *